MedPath

Dose-Response Effects of Inspiratory Muscle Strength Training on Blood Pressure and Vascular Function

Not Applicable
Not yet recruiting
Conditions
Systolic Hypertension
Brachial Artery Flow-mediated Dilation
Registration Number
NCT07109739
Lead Sponsor
University of Minnesota
Brief Summary

This study will assess the dose-response effects of Inspiratory Muscle Strength Training (IMST) in adults with above-normal systolic blood pressure over a 6-week period.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
144
Inclusion Criteria
  • Age ≥18 years
  • Resting SBP ≥120 mmHg as measured during screening 1 & 2
  • Free from serious CV or metabolic diseases as identified by self-report and blood chemistry analysis.
  • No contraindications to IMST (recent abdominal surgery, ruptured eardrum, asthma with very low symptom perception, fractured ribs, or pneumothorax)
  • Language: English-speaking, with ability to comprehend study materials and instructions.
  • Pre-visit Compliance: Willing to comply with pre-visit instructions (avoiding food and caffeine ≥ 3 hours, vigorous exercise, alcohol, and non-prescribed medications ≥ 24 hours) prior to each measurement visit.
  • Lifestyle: Non-smokers (defined as self-report of not smoking cigarettes or vaping over the past year).
Exclusion Criteria
  • Self-report of history of cardiovascular disease, or conditions affecting the ear (e.g., ruptured eardrum).
  • Recent abdominal surgery or presence of an abdominal hernia.
  • Asthma with very low symptom perception, frequent severe exacerbations, or abnormally low perception of dyspnea.
  • Ruptured eardrum or any other condition of the ear.
  • Markedly elevated left ventricular end-diastolic volume and pressure.
  • Current respiratory conditions such as a cold, sinusitis, or respiratory tract infection (participants may be included once they recover from the respiratory condition).
  • Female-Specific: Pregnant or planning to become pregnant during the study period.
  • Compliance: Unable or unwilling to comply with pre-visit restrictions (e.g., avoiding caffeine, alcohol, and exercise within specified hours before visits).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Systolic Blood Pressure at 6 WeeksWeek 6

To determine resting SBP before and after 6 weeks of IMST 15, IMST 30, or IMST 45 (75% PI max for all groups) in men and women aged ≥18 years with resting SBP ≥120 mmHg.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

University of Minnesota
🇺🇸Minneapolis, Minnesota, United States
Favian Morales
Contact
786-516-4020
moral537@umn.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.